<DOC>
	<DOCNO>NCT00393835</DOCNO>
	<brief_summary>To evaluate clinical efficacy safety patient Laryngopharyngitis Tonsillitis Acute Bacterial Rhinosinusitis receive dose 2 g azithromycin SR formulation .</brief_summary>
	<brief_title>A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis Tonsillitis Acute Bacterial Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Tonsillitis</mesh_term>
	<criteria>Patients diagnose Laryngopharyngitis Tonsillitis Acute Bacterial Rhinosinusitis Severe underlie disease ; patient drug clinical evaluation difficult confounding disease .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>